Advertisement

American Journal of Clinical Dermatology

, Volume 16, Issue 3, pp 147–165 | Cite as

Complementary and Alternative Medicine for Psoriasis: What the Dermatologist Needs to Know

  • Whitney Talbott
  • Nana Duffy
Review Article

Abstract

Complementary and alternative medicine (CAM) use is common among patients with psoriasis. CAM modalities include traditional Chinese medicine (TCM), herbal therapies, dietary supplements, climatotherapy, and mind/body interventions. In this review, evidence from clinical trials investigating the efficacy of CAM for psoriasis is reviewed. There is a large amount of evidence from controlled trials that have shown that the combination of TCM with traditional therapies for psoriasis is more efficacious than traditional therapies alone. Herbal therapies that have the most evidence for efficacy are Mahonia aquifolium and indigo naturalis, while there is a smaller amount of evidence for aloe vera, neem, and extracts of sweet whey. Dietary supplementation in patients with psoriasis demonstrates consistent evidence supporting the efficacy of fish oil supplements. Zinc supplementation has not been shown to be effective; however, some evidence is available (albeit conflicting) for vitamin D, vitamin B12, and selenium supplementation. Overwhelming evidence supports the effectiveness of Dead Sea climatotherapy. Finally, mindfulness-based stress reduction can be helpful as adjuvant treatment of psoriasis. There are potential benefits to these modalities, but also potential side issues. Concerns with CAM include, but are not limited to, contamination of TCM products with heavy metals or corticosteroids, systemic toxicity or contact dermatitis from herbal supplements, and ultraviolet light-induced carcinomas from climatotherapy. Dermatologists should be aware of these benefits and side effects to allow for informed discussions with their patients.

Keywords

Psoriasis Traditional Chinese Medicine Acitretin Alpha Lipoic Acid Herbal Supplement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Conflicts of interest

Whitney Talbott and Nana Duffy have no conflicts of interest to declare.

Funding

No sources of funding were used to assist in the preparation of this manuscript.

References

  1. 1.
    Fuhrmann T, Smith N, Tausk F. Use of complementary and alternative medicine among adults with skin disease: updated results from a national survey. J Am Acad Dermatol. 2010;63(6):1000–5.PubMedCrossRefGoogle Scholar
  2. 2.
    Fleischer AB Jr, et al. Alternative therapies commonly used within a population of patients with psoriasis. Cutis. 1996;58(3):216–20.PubMedGoogle Scholar
  3. 3.
    Ben-Arye E, et al. Complementary medicine and psoriasis: linking the patient’s outlook with evidence-based medicine. Dermatology. 2003;207(3):302–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Jensen P. Use of alternative medicine by patients with atopic dermatitis and psoriasis. Acta Derm Venereol. 1990;70(5):421–4.PubMedGoogle Scholar
  5. 5.
    Damevska K, et al. Complementary and alternative medicine use among patients with psoriasis. Dermatol Ther. 2014;27(5):281–3.PubMedCrossRefGoogle Scholar
  6. 6.
    Kim GW, et al. Comparative analysis of the use of complementary and alternative medicine by Korean patients with androgenetic alopecia, atopic dermatitis and psoriasis. J Eur Acad Dermatol Venereol. 2013;27(7):827–35.PubMedCrossRefGoogle Scholar
  7. 7.
    Kawada A, et al. A survey of psoriasis patients in Japan from 1982 to 2001. J Dermatol Sci. 2003;31(1):59–64.PubMedCrossRefGoogle Scholar
  8. 8.
    Magin PJ, et al. Complementary and alternative medicine therapies in acne, psoriasis, and atopic eczema: results of a qualitative study of patients’ experiences and perceptions. J Altern Complement Med. 2006;12(5):451–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Smith N, et al. Use of complementary and alternative medicine among adults with skin disease: results from a national survey. J Am Acad Dermatol. 2009;60(3):419–25.PubMedCrossRefGoogle Scholar
  10. 10.
    Eisenberg DM, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA. 1998;280(18):1569–75.PubMedCrossRefGoogle Scholar
  11. 11.
    See A, et al. Use of complementary and alternative medicine among dermatology outpatients in Singapore. Australas J Dermatol. 2011;52(1):7–13.PubMedCrossRefGoogle Scholar
  12. 12.
    Landis ET, et al. Complementary and alternative medicine use in dermatology in the United States. J Altern Complement Med. 2014;20(5):392–8.PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Tang JL, Liu BY, Ma KW. Traditional Chinese medicine. Lancet. 2008;372(9654):1938–40.PubMedCrossRefGoogle Scholar
  14. 14.
    Zhang CS, et al. Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: a systematic review. Int J Dermatol. 2014;53(11):1305–18.PubMedCrossRefGoogle Scholar
  15. 15.
    Yu JJ, et al. Add-on effect of chinese herbal medicine bath to phototherapy for psoriasis vulgaris: a systematic review. Evid Based Complement Alternat Med. 2013;2013:673078.PubMedCentralPubMedGoogle Scholar
  16. 16.
    Deng S, et al. Topical herbal medicine combined with pharmacotherapy for psoriasis: a systematic review and meta-analysis. Arch Dermatol Res. 2013;305(3):179–89.PubMedCrossRefGoogle Scholar
  17. 17.
    Smith N, et al. Complementary and alternative medicine for psoriasis: a qualitative review of the clinical trial literature. J Am Acad Dermatol. 2009;61(5):841–56.PubMedCrossRefGoogle Scholar
  18. 18.
    Shenghua Y. Clinical research in treating psoriasis by point-injection of magnetic blood. Int J Clin Acupunct. 2002;13:239–42.Google Scholar
  19. 19.
    Deng S, et al. Plant extracts for the topical management of psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2013;169(4):769–82.PubMedCrossRefGoogle Scholar
  20. 20.
    Dhanabal SP, et al. Evaluation of the antipsoriatic activity of Aloe vera leaf extract using a mouse tail model of psoriasis. Phytother Res. 2012;26(4):617–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Lin YK, et al. Efficacy and safety of Indigo naturalis extract in oil (Lindioil) in treating nail psoriasis: a randomized, observer-blind, vehicle-controlled trial. Phytomedicine. 2014;21(7):1015–20.PubMedCrossRefGoogle Scholar
  22. 22.
    Deng S, et al. Topical herbal formulae in the management of psoriasis: systematic review with meta-analysis of clinical studies and investigation of the pharmacological actions of the main herbs. Phytother Res. 2014;28(4):480–97.PubMedCrossRefGoogle Scholar
  23. 23.
    May BH, et al. Oral herbal medicines for psoriasis: a review of clinical studies. Chin J Integr Med. 2012;18(3):172–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Pandey SS, Jha AK, Kaur V. Aqueous extract of neem leaves in treatment of psoriasis vulgaris. Indian J Dermatol Venereol Leprol. 1994;60:63–7.Google Scholar
  25. 25.
    Poulin Y, et al. XP-828L in the treatment of mild to moderate psoriasis: randomized, double-blind, placebo-controlled study. Altern Med Rev. 2007;12(4):352–9.PubMedGoogle Scholar
  26. 26.
    De Caterina R. n-3 fatty acids in cardiovascular disease. N Engl J Med. 2011;364(25):2439–50.PubMedCrossRefGoogle Scholar
  27. 27.
    Millsop JW, et al. Diet and psoriasis, part III: role of nutritional supplements. J Am Acad Dermatol. 2014;71(3):561–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Collier PM, et al. Effect of regular consumption of oily fish compared with white fish on chronic plaque psoriasis. Eur J Clin Nutr. 1993;47(4):251–4.PubMedGoogle Scholar
  29. 29.
    Chan MM. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol. 1995;49(11):1551–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Kurd SK, et al. Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: a prospective clinical trial. J Am Acad Dermatol. 2008;58(4):625–31.PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Ryan JL, et al. Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patients. Support Care Cancer. 2012;20(7):1479–89.PubMedCentralPubMedCrossRefGoogle Scholar
  32. 32.
    Brazzelli V, et al. Homocysteine, vitamin B12 and folic acid levels in psoriatic patients and correlation with disease severity. Int J Immunopathol Pharmacol. 2010;23(3):911–6.PubMedGoogle Scholar
  33. 33.
    Segal R, et al. Anemia, serum vitamin B12, and folic acid in patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus. Rheumatol Int. 2004;24(1):14–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Baker H, Comaish JS. Is vitamin B12 of value in psoriasis? Br Med J. 1962;2(5321):1729–30.PubMedCentralPubMedCrossRefGoogle Scholar
  35. 35.
    Ruedemann R Jr. Treatment of psoriasis with large doses of vitamin B12, 1,100 micrograms per cubic centimeter; preliminary clinical report. AMA Arch Derm Syphilol. 1954;69(6):738–9.PubMedCrossRefGoogle Scholar
  36. 36.
    Stucker M, et al. Vitamin B(12) cream containing avocado oil in the therapy of plaque psoriasis. Dermatology. 2001;203(2):141–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Serwin AB, et al. Selenium status in psoriasis and its relationship with alcohol consumption. Biol Trace Elem Res. 2002;89(2):127–37.PubMedCrossRefGoogle Scholar
  38. 38.
    Kharaeva Z, Gostova E, De Luca C, Raskovic D, Korkina L. Clinical and biochemical effects of coenzyme Q(10), vitamin E, and selenium supplementation to psoriasis patients. Nutrition. 2009;25(3):295–302PubMedCrossRefGoogle Scholar
  39. 39.
    Dawe RS, et al. A randomized controlled comparison of the efficacy of Dead Sea salt balneophototherapy vs. narrowband ultraviolet B monotherapy for chronic plaque psoriasis. Br J Dermatol. 2005;153(3):613–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Gambichler T, et al. Balneophototherapy of psoriasis: highly concentrated salt water versus tap water. a randomized, one-blind, right/left comparative study. Photodermatol Photoimmunol Photomed. 2001;17(1):22–5.PubMedCrossRefGoogle Scholar
  41. 41.
    Halevy S, Giryes H, Friger M, Sukenik S. Dead sea bath salt for the treatment of psoriasis vulgaris: a double-blind controlled study. J Eur Acad Dermatol Venereol. 1997;9:237–42.CrossRefGoogle Scholar
  42. 42.
    Leaute-Labreze C, et al. Saline spa water or combined water and UV-B for psoriasis vs conventional UV-B: lessons from the Salies de Bearn randomized study. Arch Dermatol. 2001;137(8):1035–9.PubMedGoogle Scholar
  43. 43.
    Brockow T, et al. A pragmatic randomized controlled trial on the effectiveness of highly concentrated saline spa water baths followed by UVB compared to UVB only in moderate to severe psoriasis. J Altern Complement Med. 2007;13(7):725–32.PubMedCrossRefGoogle Scholar
  44. 44.
    Brockow T, et al. A pragmatic randomized controlled trial on the effectiveness of low concentrated saline spa water baths followed by ultraviolet B (UVB) compared to UVB only in moderate to severe psoriasis. J Eur Acad Dermatol Venereol. 2007;21(8):1027–37.PubMedCrossRefGoogle Scholar
  45. 45.
    Cheesbrough MJ. Treatment of psoriasis with 30 % Dead Sea salt lotion. J Dermatol Treat. 1992;3:201–3.CrossRefGoogle Scholar
  46. 46.
    Hodak E, et al. Climatotherapy at the Dead Sea is a remittive therapy for psoriasis: combined effects on epidermal and immunologic activation. J Am Acad Dermatol. 2003;49(3):451–7.PubMedCrossRefGoogle Scholar
  47. 47.
    Harari M, et al. Patients with early-onset psoriasis achieve better results following Dead Sea climatotherapy. J Eur Acad Dermatol Venereol. 2012;26(5):554–9.PubMedCrossRefGoogle Scholar
  48. 48.
    Shani J, et al. Indications, contraindications and possible side-effects of climatotherapy at the Dead-Sea. Int J Dermatol. 1997;36(7):481–92.PubMedCrossRefGoogle Scholar
  49. 49.
    Kurd SK, et al. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol. 2010;146(8):891–5.PubMedCentralPubMedGoogle Scholar
  50. 50.
    Gaston L, et al. Psychological stress and psoriasis: experimental and prospective correlational studies. Acta Derm Venereol Suppl (Stockh). 1991;156:37–43.PubMedGoogle Scholar
  51. 51.
    Tausk F, Whitmore SE. A pilot study of hypnosis in the treatment of patients with psoriasis. Psychother Psychosom. 1999;68(4):221–5.PubMedCrossRefGoogle Scholar
  52. 52.
    Kabat-Zinn J, et al. Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA). Psychosom Med. 1998;60(5):625–32.PubMedCrossRefGoogle Scholar
  53. 53.
    Zachariae R, et al. Effects of psychologic intervention on psoriasis: a preliminary report. J Am Acad Dermatol. 1996;34(6):1008–15.PubMedCrossRefGoogle Scholar
  54. 54.
    Keinan G, Segal A, Gal U, Brenner S. Stress management for psoriasis patients: the effectiveness of biofeedback and relaxation techniques. Stress Med. 1995;11:235–41.CrossRefGoogle Scholar
  55. 55.
    Cohen PA. Hazards of hindsight: monitoring the safety of nutritional supplements. N Engl J Med. 2014;370(14):1277–80.PubMedCrossRefGoogle Scholar
  56. 56.
    Blumenthal M, Gruenwald J, Hall T, Rister RS. The Complete German Commission E Monographs: therapeutic guide to herbal medicine. Boston: Integrative Medicine Communications; 1998.Google Scholar
  57. 57.
    Interactions with herbal products. what do we know? Drug Ther Bull. 2014;52(2):18–21.CrossRefGoogle Scholar
  58. 58.
    Wu ML, et al. Lead, mercury, and arsenic poisoning due to topical use of traditional Chinese medicines. Am J Med. 2013;126(5):451–4.PubMedCrossRefGoogle Scholar
  59. 59.
    Hon KL, et al. Paradoxical use of oral and topical steroids in steroid-phobic patients resorting to traditional Chinese medicines. World J Pediatr. 2012;8(3):263–7.PubMedCrossRefGoogle Scholar
  60. 60.
    O’Driscoll J, Burden AD, Kingston TP. Potent topical steroid obtained from a Chinese herbalist. Br J Dermatol. 1992;127(5):543–4.PubMedCrossRefGoogle Scholar
  61. 61.
    Kim HJ, et al. A case of squamous cell carcinoma and arsenic keratoses in a patient with vitiligo taking Chinese arsenic medicine. Int J Dermatol. 2013;52(12):1542–3.PubMedCrossRefGoogle Scholar
  62. 62.
    Wu ML, Deng JF. Toxic epidermal necrolysis after extensive dermal use of realgar-containing (arsenic sulfide) herbal ointment. Clin Toxicol (Phila). 2013;51(8):801–3.PubMedCrossRefGoogle Scholar
  63. 63.
    Goldman JA, Myerson G. Chinese herbal medicine: camouflaged prescription antiinflammatory drugs, corticosteroids, and lead. Arthritis Rheum. 1991;34(9):1207.PubMedCrossRefGoogle Scholar
  64. 64.
    Harris ES, et al. Heavy metal and pesticide content in commonly prescribed individual raw Chinese Herbal Medicines. Sci Total Environ. 2011;409(20):4297–305.PubMedCentralPubMedCrossRefGoogle Scholar
  65. 65.
    Bedi MK, Shenefelt PD. Herbal therapy in dermatology. Arch Dermatol. 2002;138(2):232–42.PubMedCrossRefGoogle Scholar
  66. 66.
    Phua DH, Zosel A, Heard K. Dietary supplements and herbal medicine toxicities: when to anticipate them and how to manage them. Int J Emerg Med. 2009;2(2):69–76.PubMedCentralPubMedCrossRefGoogle Scholar
  67. 67.
    Debbaneh M, et al. Diet and psoriasis, part I: impact of weight loss interventions. J Am Acad Dermatol. 2014;71(1):133–40.PubMedCrossRefGoogle Scholar
  68. 68.
    Poikolainen K, et al. Alcohol intake: a risk factor for psoriasis in young and middle aged men? BMJ. 1990;300(6727):780–3.PubMedCentralPubMedCrossRefGoogle Scholar
  69. 69.
    Qureshi AA, et al. Alcohol intake and risk of incident psoriasis in US women: a prospective study. Arch Dermatol. 2010;146(12):1364–9.PubMedCentralPubMedCrossRefGoogle Scholar
  70. 70.
    Kimball AB, et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol. 2008;58(6):1031–42.PubMedCentralPubMedCrossRefGoogle Scholar
  71. 71.
    Saravanan P, et al. Cardiovascular effects of marine omega-3 fatty acids. Lancet. 2010;376(9740):540–50.PubMedCrossRefGoogle Scholar
  72. 72.
    Krishna S, et al. Influence of omega-3 fatty acids on triglyceride levels in patients using isotretinoin. JAMA Dermatol. 2015;151(1):101–2.PubMedCentralPubMedCrossRefGoogle Scholar
  73. 73.
    Labdoor. Top 10 fish oil supplements. https://labdoor.com/rankings/fish-oil.
  74. 74.
    Ross AC, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53–8.PubMedCentralPubMedCrossRefGoogle Scholar
  75. 75.
    Bhatia BK, et al. Diet and psoriasis, part II: celiac disease and role of a gluten-free diet. J Am Acad Dermatol. 2014;71(2):350–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Klein A, et al. A randomized clinical trial in psoriasis: synchronous balneophototherapy with bathing in Dead Sea salt solution plus narrowband UVB vs. narrowband UVB alone (TOMESA-study group). J Eur Acad Dermatol Venereol. 2011;25(5):570–8.PubMedCrossRefGoogle Scholar
  77. 77.
    Capella GL, Finzi AF. Complementary therapy for psoriasis. Dermatol Ther. 2003;16(2):164–74.PubMedCrossRefGoogle Scholar
  78. 78.
    Liu XJ, Shi N, Chen YJ. Binghuang ointment for stable psoriasis vulgaris. Hubei J Tradit Chin Med. 2012;34(6):46.Google Scholar
  79. 79.
    Zhang Z. Clinical observation of intregration of traditional and western medicine for 56 patients with psoriasis vulgaris. Guide China Med. 2012;16:275–6.Google Scholar
  80. 80.
    Zheng X. Xiaoyin Kebi Decoction for 60 psoriasis vulgaris patients. Henan Tradit Chin Med. 2011;4:383–4.Google Scholar
  81. 81.
    Luo X. The observe of clinical theraputic effect on the treatment of psoriasis with acitretin capsules combined with Chinese herbal compound [master’s thesis]. China: Hubei University of Chinese Medicine; 2010.Google Scholar
  82. 82.
    Wang H, Sun Y, Li X. Efficacy of Chinese medicine integrated with western medicine in 42 cases of psoriasis vulgaris. China Mod Dr. 2010;48(30):55–67.Google Scholar
  83. 83.
    Wu SM, Wu Y, Bai Y, et al. Clinical observation of Acitretin combined with Yinwiekang for psoriasis. Chin J Dermatol Venereol Integr Tradit Western Med. 2009;4:228–9.Google Scholar
  84. 84.
    Yang H, Wu Y, Ding Y. Thymosin combined with Chinese herbal bath for psoriasis vulgaris in 82 cases. Shandong Med J. 2008;48(6):75.Google Scholar
  85. 85.
    Yang X, Du Y, Hu P, Chen D. Acitretin combined with Chinese herbal steam for psoriasis vulgaris. Chin J Dermatol Venereol. 2008;22(5):285–6.Google Scholar
  86. 86.
    Feng Y, Zhao Q, Li Y, Cai R, Bai X. Efficacy of Chinese herbal bath in the treatment of psoriasis vulgaris. China J Lepr Skin Dis. 2007;23(1):88–9.Google Scholar
  87. 87.
    Mao H, Mao Y. Clinical observation of integration of Chinese medicine and western medicine treatment for psoriasis vulgaris. China Healthc Innov. 2007;19:64.Google Scholar
  88. 88.
    Han C, Peng J, Ye X. The clinical observation of the combination of Binghuangfule ointment and clobetasol cream for treating psoriasis vulgaris. Chin J Dermatol Venereol. 2006;20(2):123–5.Google Scholar
  89. 89.
    Tang Y. Medicated bath for psoriasis vulgaris. Chin Nurs Res. 2004;18:1180.Google Scholar
  90. 90.
    Wang M, Sui S, Gong A, Guan Y, Kuang X. Efficacy of Yinxieling ointment on 675 cases. Chin Tradit Pat Med. 1990;12(11):21.Google Scholar
  91. 91.
    Yang YD, Zhang W, Gao WY, Yang WT, et al. Liubai Baibi cataplasm for psoriasis. J China Tradit Chin Med Inf. 2011;3:148.Google Scholar
  92. 92.
    Xu J, Zhang C, Qu X. Clinical and experimental study on effect of qinbai ointment in treating psoriasis in the active stage of blood-heat syndrome type. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009;29:614–8.PubMedGoogle Scholar
  93. 93.
    Zhou N, Bai Y, Man XH, et al. Effect of new Pulain ointment in treating psoriasis of blood-heat syndrome: a randomized controlled trial. Chin J Integr Med. 2009;15:409–14.PubMedCrossRefGoogle Scholar
  94. 94.
    Zhu L, Zhang H, Duan Y. Chinese herbal medicine “Xiaoxuanling” for 85 participants with psoriasis vulgaris. Youjiang Med J. 2008;36:230–1.Google Scholar
  95. 95.
    Song P, Yan ZF, Xu X. Clinical observation on effect of compound E-bei ointment in treating plaque psoriasis. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007;27:352–4.PubMedGoogle Scholar
  96. 96.
    Gao WY, Zhang W, Yang YD, Zhou CY, Bei YC. Liubei Beibi cream for psoriasis vulgaris. J Ext Ther TCM. 2006;15:26–7.Google Scholar
  97. 97.
    Lu YP, Miao XR. The topical application of Queyin tincture on psoriasis. Liaoning J Trad Chin Med. 2004;31:394.Google Scholar
  98. 98.
    Wang JX, Zhu MF, Xiang LP, Xiao YL. Chinese medicinal bath for psoriasis vulgaris. J Chin Phys. 2002;1:96–7.Google Scholar
  99. 99.
    Shi XL, Pan YM, Ma HY, Yang XF. Treatment of psoriasis vulgaris by NB-UVB combined with traditional Chinese materia medica bath: a clinical observation. Chin J Laser Med Surg. 2011;5:314–7.Google Scholar
  100. 100.
    Wang ZX, Wang HJ, Yu ZH, et al. Clinical observation of Chinese herbal medicine bath combined with NB-UVB for psoriasis vulgaris. J Henan Univers. 2011;3:226–7.Google Scholar
  101. 101.
    Wu B, Chen XD, Xia D, et al. Clinical observation of Chinese herbal medicine combined with NB-UVB for psoriasis vulgaris. Chin J Integr Tradit Western Med. 2011;5:304–5.Google Scholar
  102. 102.
    Lin GS, Wang HY, Luo DF, et al. Chinese herbal medicine bath combined with NB-UVB for psoriasis vulgaris. Acta Universitatis Medicinalis Anhui. 2010;3:404–6.Google Scholar
  103. 103.
    Wu LN, Huang LN, Xue RZ. Clinical observation and nursing of psoriasis vulgaris treated with narrow-band UVB combined with Chinese herb bath. J Diagn Ther Dermatol Venereol. 2010;3:242–4.Google Scholar
  104. 104.
    Gu Y, Liu HX, Zhang CH, et al. Clinical observation of traditional chinese medical herbs bath combined with narrow-band ultraviolet B for the treatment of psoriasis vulgaris. Chin J Dermatol Venereol. 2009;4:243–4.Google Scholar
  105. 105.
    Cui BN, Sun YX, Liu WL. Clinical efficacy of narrow band ultraviolet bin combined with yuyin recipe in treating psoriasis vulgaris. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008;28(4):355–7.PubMedGoogle Scholar
  106. 106.
    Liu HQ, Lei MJ, Wang GH. Clinical observation of Chinese herbal medicine bath combined with NB-UVB for 40 patients with psoriasis vulgaris. N J Tradit Chin Med. 2005;2:53–4.Google Scholar
  107. 107.
    Thompson Healthcare. PDR for Herbal Medicines, 4th ed. Thomson Reuters; 2007.Google Scholar
  108. 108.
    Steele T, Rogers CJ, Jacob SE. Herbal remedies for psoriasis: what are our patients taking? Dermatol Nurs. 2007;19(5):448–50, 457–63.Google Scholar
  109. 109.
    Chavez ML, Jordan MA, Chavez PI. Evidence-based drug–herbal interactions. Life Sci. 2006;78(18):2146–57.PubMedCrossRefGoogle Scholar
  110. 110.
    Natural Medicines Comprehensive Database. Available at: http://naturaldatabase.therapeuticresearch.com. Accessed 18 Jan 2015.
  111. 111.
    FDA Poisonous Plant Database. Available at: http://www.accessdata.fda.gov/scripts/plantox/. Accessed 18 Jan 2015.
  112. 112.
    MediHerb. Potential herb–drug interactions for commonly used herbs. 18 Jan 2015. Available at: https://www.standardprocess.com/MediHerb-Document-Library/Catalog-Files/herb-drug-interaction-chart.pdf. Accessed 18 Jan 2015.

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  1. 1.University of Rochester School of MedicineRochesterUSA
  2. 2.University of Rochester Medical CenterRochesterUSA

Personalised recommendations